Combating a resurgence of poliomyelitis through public health surveillance and vaccination.
10.47102/annals-acadmedsg.2022390
- Author:
Chia Yin CHONG
1
;
Kai Qian KAM
;
Chee Fu YUNG
Author Information
1. Infectious Disease Service, Department of Paediatrics, KK Women's and Children's Hospital, Singapore.
- Publication Type:Journal Article
- MeSH:
Child;
Humans;
Infant;
Public Health Surveillance;
Pandemics;
Wastewater;
Wastewater-Based Epidemiological Monitoring;
COVID-19/epidemiology*;
Poliomyelitis/prevention & control*;
Poliovirus;
Poliovirus Vaccine, Oral;
Vaccination;
Global Health
- From:Annals of the Academy of Medicine, Singapore
2023;52(1):17-26
- CountrySingapore
- Language:English
-
Abstract:
Poliomyelitis, or polio, is a highly infectious disease and can result in permanent flaccid paralysis of the limbs. Singapore was certified polio-free by the World Health Organization (WHO) on 29 October 2000, together with 36 other countries in the Western Pacific Region. The last imported case of polio in Singapore was in 2006. Fortunately, polio is vaccine-preventable-the world saw the global eradication of wild poliovirus types 2 and 3 achieved in 2015 and 2019, respectively. However, in late 2022, a resurgence of paralytic polio cases from vaccine-derived poliovirus (VDPV) was detected in countries like Israel and the US (specifically, New York); VDPV was also detected during routine sewage water surveillance with no paralysis cases in London, UK. Without global eradication, there is a risk of re-infection from importation and spread of wild poliovirus or VDPV, or new emergence and circulation of VDPV. During the COVID-19 pandemic, worldwide routine childhood vaccination coverage fell by 5% to 81% in 2020-2021. Fortunately, Singapore has maintained a constantly high vaccination coverage of 96% among 1-year-old children as recorded in 2021. All countries must ensure high poliovirus vaccination coverage in their population to eradicate poliovirus globally, and appropriate interventions must be taken to rectify this if the coverage falters. In 2020, WHO approved the emergency use listing of a novel oral polio vaccine type 2 for countries experiencing circulating VDPV type 2 outbreaks. Environmental and wastewater surveillance should be implemented to allow early detection of "silent" poliovirus transmission in the population, instead of relying on clinical surveillance of acute flaccid paralysis based on case definition alone.
